Priority Review Drugs Approved by the Food and Drug Administration and the European Medicines Agency: Differences and Policy Implications
Saad Alqahtani1 and Rosa Rodriguez-Monguio, PhD, MS2
(1)Massachusetts College of Pharmacy and Health Sciences, Boston, MA, (2)University of Massachusetts, Amherst, Amherst, MA